tiprankstipranks
Advertisement
Advertisement

ANNX Stock Latest News

Annexon initiated with an Underperform at Citizens
The FlyAnnexon initiated with an Underperform at Citizens
3d ago
ANNX
Annexon price target raised to $25 from $11 at Needham
PremiumThe Fly
Annexon price target raised to $25 from $11 at Needham
9d ago
ANNX
Annexon to present vonaprument data at ASRS
PremiumThe Fly
Annexon to present vonaprument data at ASRS
9d ago
ANNX
Nedham biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Nedham biotech analysts hold an analyst/industry conference call
21d ago
ANNX
Annexon Stockholders Approve Directors, Compensation and Share Increase
PremiumCompany Announcements
Annexon Stockholders Approve Directors, Compensation and Share Increase
1M ago
8K
ANNX
Annexon initiated with a Neutral at Goldman Sachs
PremiumThe FlyAnnexon initiated with a Neutral at Goldman Sachs
2M ago
ANNX
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
Premium
Ratings
Annexon: Advancing Complement Pipeline and Strong Cash Runway Support Buy Rating; $11 Price Target Reiterated
3M ago
ANNX
Annexon reports Q1 EPS (23c), consensus (30c)
Premium
The Fly
Annexon reports Q1 EPS (23c), consensus (30c)
3M ago
ANNX
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
PremiumCompany Announcements
Cyber Risks Threaten Annexon Biosciences’ Clinical Operations, Reputation and Financial Health
4M ago
ANNX
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
PremiumThe Fly
Chardan sees positive read-through to Annexon’s vonaprument from Apellis deal
4M ago
ANNX
APLS
Annexon files automatic mixed securities shelf
PremiumThe Fly
Annexon files automatic mixed securities shelf
4M ago
ANNX
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
PremiumRatings
Annexon: Solid Cash Runway and 2026 Clinical Catalysts Underpin Buy Rating
4M ago
ANNX
Annexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
PremiumRatingsAnnexon (ANNX): Late‑Stage Complement Pipeline and Strong Cash Runway Support Attractive Risk‑Reward and Buy Rating
4M ago
ANNX
Annexon reports Q4 EPS (28c), consensus (32c)
Premium
The Fly
Annexon reports Q4 EPS (28c), consensus (32c)
4M ago
ANNX
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
Premium
Ratings
Undervalued Vision Preservation Opportunity: Buy Recommendation on Annexon Driven by Differentiated GA Therapy vonaprument Ahead of Pivotal Phase 3 Data
4M ago
ANNX
ANNX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ANNX Upcoming Earnings Report: What to Expect?
5M ago
ANNX
Annexon Biosciences Announces Planned Retirement of Board Chairman
PremiumCompany Announcements
Annexon Biosciences Announces Planned Retirement of Board Chairman
5M ago
8K
ANNX
Annexon Highlights Late-Stage C1q Pipeline and 2026 Outlook
PremiumCompany Announcements
Annexon Highlights Late-Stage C1q Pipeline and 2026 Outlook
6M ago
8K
ANNX
Annexon highlights its 2026 strategic priorities
PremiumThe Fly
Annexon highlights its 2026 strategic priorities
6M ago
ANNX
Annexon Biosciences outlines pivotal 2026 milestones and outlook
PremiumCompany AnnouncementsAnnexon Biosciences outlines pivotal 2026 milestones and outlook
6M ago
8K
ANNX
Annexon submits MAA to EMA for tanruprubart
Premium
The Fly
Annexon submits MAA to EMA for tanruprubart
7M ago
ANNX
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
Premium
Weekend Updates
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
7M ago
BRO
ANNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >